Stryker Corp
SYK
310.00
-3.08
-0.98%
Stryker Corp
US · SYK
#199 by market cap
Listed 1970
310.00
-3.08
-0.98%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:31
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 7 in the most recent period (2026/Q4).
- Total institutional ownership fell 0.1 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 81.27% -0.13pp
- Institutions
- 2,622 -7
- As of
- 2026/Q4 vs. prior period
Holder types
Mutual Fund67.68%
Individual/Insider9.07%
Public Company4.54%
Private Company2.78%
Government Pension Fund1.78%
Sovereign Wealth Fund1.35%
Hedge Fund1.28%
Family Office/Trust0.76%
Corporate Pension Plan0.33%
Other10.43%
Top holders as of 2026-09-30
BlackRock
7.12% · 27.12M sh
Vanguard Capital Management, LLC
6.48% · 24.69M sh
John Brown
5.27% · 20.06M sh
State Street Global Advisors
4.15% · 15.80M sh
Greenleaf Trust National Association
3.98% · 15.16M sh
Other
73.22%
Ronda Stryker
3.66% · 13.92M sh
Wellington Management Group
2.63% · 10.02M sh
T. Rowe Price Group, Inc.
3.13% · 11.93M sh
J.P. Morgan Asset Management, Inc.
2.27% · 8.63M sh
Geode Capital Management, LLC
2.10% · 8.01M sh
Vanguard Portfolio Management, LLC
2.07% · 7.88M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 13 buys · 31 sells
| Name | Role | Stake |
|---|---|---|
| John Brown | Former Chairperson | 5.27% |
| Ronda Stryker | Independent Director | 3.66% |
| Kevin Lobo | Chairperson & CEO | 0.06% |
| J. Pierce | Group President of MedSurg & Neurotechnology | 0.02% |
| Spencer Stiles | President | 0.02% |
| Yin Becker | Former VP of Communications, Public Affairs & Corp. Marketing and Chief Corp. Affairs Officer | 0.01% |
| Viju Menon | Group President of Global Quality & Operations | 0.00% |
| Allan Golston | Former Independent Director | 0.00% |
| Dylan Crotty | Group President of Orthopaedics | 0.00% |
| Glenn Boehnlein | Former Advisor | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-05 | Ronda Stryker | Independent Director | Open Market Disposition | -550,000 | $323.19–327.69 |
| 2026-09-23 | Preston Wells | Vice President | Other Disposition | -109 | -- |
| 2026-09-21 | Preston Wells | Vice President | Other Disposition | -2,738 | -- |
| 2026-08-31 | Emily Baculik | VP, Chief Accounting Officer & Corporate Controller | Initial Statement of Beneficial | 0 | -- |
| 2026-08-20 | Dylan Crotty | Group President of Orthopaedics | Open Market Disposition | -441 | $328.61 |
| 2026-08-18 | Ronda Stryker | Independent Director | Open Market Disposition | -350,000 | $331.74–343.47 |
| 2026-08-17 | Ronda Stryker | Independent Director | Intent to Sell (Form 144) | -350,000 | $335.00 |
| 2026-08-17 | Debra King | VP and Chief Digital & Information Officer | Open Market Disposition | -826 | $336.30 |
| 2026-07-31 | M. Fink | VP & Chief Human Resources Officer | Sale to Issuer | -111 | $325.70 |
| 2026-07-31 | Robert Fletcher | VP & Chief Legal Officer | Sale to Issuer | -94 | $325.70 |
| 2026-07-31 | Debra King | VP and Chief Digital & Information Officer | Sale to Issuer | -533 | $325.70 |
| 2026-07-31 | Kimberly Montagnino | -- | Sale to Issuer | -155 | $325.70 |
| 2026-05-31 | Spencer Stiles | President | Other Disposition | -1,607 | -- |
| 2026-05-27 | Robert Fletcher | VP & Chief Legal Officer | Automatic Disposition | -4,544 | $304.23–310.22 |
| 2026-05-25 | Ronda Stryker | Independent Director | Open Market Disposition | -310,000 | $310.77–315.11 |
| 2026-05-10 | M. Fink | VP & Chief Human Resources Officer | Derivative Exercise and Sale | -21,582 | $154.14–294.23 |
| 2026-05-10 | M. Fink | VP & Chief Human Resources Officer | Open Market Disposition | -3,500 | $283.45 |
| 2026-05-05 | Lisa Skeete Tatum | Independent Director | Other Acquisition | +762 | -- |
| 2026-05-05 | Ronda Stryker | Independent Director | Other Acquisition | +762 | -- |
| 2026-05-05 | Mary Brainerd | Independent Director | Other Acquisition | +762 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:31:25 · For reference only, not investment advice and not tailored to your situation.
Stryker Corp discussion 0 comments